209 related articles for article (PubMed ID: 18326897)
1. Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy.
Oehadian A; Fadjari TH
Acta Med Indones; 2008 Jan; 40(1):29-33. PubMed ID: 18326897
[TBL] [Abstract][Full Text] [Related]
2. Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature.
Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR
Anticancer Res; 2005; 25(3c):2509-13. PubMed ID: 16080485
[TBL] [Abstract][Full Text] [Related]
3. Neutropenic enterocolitis affecting the transverse colon: an unusual complication of chemotherapy.
Ramsingh J; Bolln C; Hodnett R; Al-Ani A
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24792023
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100
[TBL] [Abstract][Full Text] [Related]
5. Neutropenic enterocolitis in acute leukemia: diagnostic and therapeutic dilemma.
Capria S; Vitolo D; Cartoni C; Dessanti L; Micozzi A; Mandelli F; Meloni G
Ann Hematol; 2004 Mar; 83(3):195-7. PubMed ID: 15064870
[TBL] [Abstract][Full Text] [Related]
6. Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer.
Honkoop AH; Luykx-de Bakker SA; Hoekman K; Meyer S; Meyer OW; van Groeningen CJ; van Diest PJ; Boven E; van der Wall E; Giaccone G; Wagstaff J; Pinedo HM
Oncologist; 1999; 4(2):106-11. PubMed ID: 10337380
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Fornier MN; Seidman AD; Theodoulou M; Moynahan ME; Currie V; Moasser M; Sklarin N; Gilewski T; D'Andrea G; Salvaggio R; Panageas KS; Norton L; Hudis C
Clin Cancer Res; 2001 Dec; 7(12):3934-41. PubMed ID: 11751485
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].
Tsutani Y; Saeki T; Aogi K; Ohsumi S; Takashima S
Gan To Kagaku Ryoho; 2005 Jun; 32(6):809-13. PubMed ID: 15984521
[TBL] [Abstract][Full Text] [Related]
9. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E
Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672
[TBL] [Abstract][Full Text] [Related]
11. Rapid diagnosis of neutropenic enterocolitis (typhlitis) by ultrasonography.
Gootenberg JE; Abbondanzo SL
Am J Pediatr Hematol Oncol; 1987; 9(3):222-7. PubMed ID: 3314548
[TBL] [Abstract][Full Text] [Related]
12. Neutropenic enterocolitis.
Singhal M; Lal A; Vyas S; Gulati A
Indian J Cancer; 2007; 44(3):122-3. PubMed ID: 18250536
[TBL] [Abstract][Full Text] [Related]
13. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.
Dranitsaris G; Rayson D; Vincent M; Chang J; Gelmon K; Sandor D; Reardon G
Am J Clin Oncol; 2008 Aug; 31(4):369-74. PubMed ID: 18845996
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting.
Burtness B; Windsor S; Holston B; DiStasio S; Staugaard-Hahn C; Abrantes J; Kneuper-Hall R; Farber L; Orell J; Bober-Sorcinelli K; Haffty BG; Reiss M
Cancer J Sci Am; 1999; 5(4):224-9. PubMed ID: 10439168
[TBL] [Abstract][Full Text] [Related]
17. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
18. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy.
Nesher L; Rolston KV
Clin Infect Dis; 2013 Mar; 56(5):711-7. PubMed ID: 23196957
[TBL] [Abstract][Full Text] [Related]
19. Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.
Takaoka E; Kawai K; Ando S; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jan; 36(1):60-3. PubMed ID: 16436462
[TBL] [Abstract][Full Text] [Related]
20. Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
Kouroussis C; Samonis G; Androulakis N; Souglakos J; Voloudaki A; Dimopoulos MA; Kotsakis T; Kakolyris S; Kalbakis K; Georgoulias V
Am J Clin Oncol; 2000 Jun; 23(3):309-13. PubMed ID: 10857900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]